Motif Bio Share Discussion Threads

[toolsmoker] 09/1/2018 10:04

This trades back to 52p now quickly

[tilly99] 09/1/2018 09:57

Where is dim Tim Short from 32pWalnuts squeezed?

[longshanks] 08/1/2018 20:11

At an individual scale, you are right; it is a sizeable investment.The point I was querying was how significant that sum of money is for a company that currently spends that amount in just a few days and has yet to establish any meaningful revenue.

[pyglet] 08/1/2018 17:56

In my books £100k is a substantial amount of cash for one person.

[longshanks] 08/1/2018 16:21

They do - and one would hope that was enough. The cost of running trials has stopped but it seems to me that they are now gearing up significant marketing spend in anticipation of sales by December this year.The likelihood is that they will need to raise more cash this year and I suspect whilst they would prefer a placing, they will instead borrow more in June if the share price isn't north of £1 by then.

[flavio_monteiro] 08/1/2018 16:12

Longshanks...They have a 20 million Debt facility!!

[longshanks] 08/1/2018 16:00

Substantial?About £100k by my b-o-f calc. They will need a bit more than that to complete commercialisation.What are the advantages to warrant holders of converting - Anyone?

[pyglet] 08/1/2018 15:47

WARRANTS HAVE BEEN EXERCISED - Substantial amount of cash injection

[chadders] 08/1/2018 15:39

Concerted buying this afternoon. Chance of an update maybe?

[w1ndjammer] 05/1/2018 12:00

Thanks for the answers guys, i think they tell their own story, i will research
properly next week when i get better internet. For now i see brokers targets
of 110p so that will do. I also see very little interest on the BB maybe i have
started buying at the right time.

WJ.

[acwill] 05/1/2018 10:37

From Globe news this morning, may explain the rise.

Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company will participate in the following event:
Cantor Antibiotics Summit
January 17, 2018
Omni Berkshire Hotel
New York, NY USA

Graham Lumsden, Chief Executive Officer, will participate in a panel discussion, “Catalysts to Look for in 2018.”

The Cantor Antibiotics Summit will bring together leading antibiotic companies to discuss: what will drive the uptake of these new products, novel ways to treat infections and important catalysts to look forward to in 2018. The Summit will consist of various panels, in addition to one-on-one and small group meetings.

[longshanks] 05/1/2018 10:10

The price turns on a sixpence: looks to me like clear manipulation as part of a stock building exercise.Doesn't really bother me. Yes we have a NASDAQ listing, but isn't this one of the problems with AIM listed shares that we are expected to accept as part of its high risk/high potential gain (or losses) rationale?

[longshanks] 05/1/2018 08:52

My understanding is that the original P3 trials undertaken by Arpida failed to show non-inferiority and hence the FDA rejected the NDA.The recent trials had this proof of non-inferiority as their principal objective.The original plan was to have a more general purpose anti-biotic, whereas now it is targeted at a select group of patients who are maltreated when given vancomycin. Whilst a select group it is still a very significant target market: renal impairment with patients suffering ABSSSI is very common.

[w1ndjammer] 04/1/2018 18:37

have not watched any presentations only got 2G for next few days.

WJ.

[w1ndjammer] 04/1/2018 18:34

Ok guys i am new here so take it easy on me, bought a few today, and looking to buy more. just a few questions.

After the FDA kicked Iclaprim into the long grass in 2009 has it been modified ?
considering the above is NDA approval pivotal to possible takeover, is this why no approach so far ?
if approved why will this drug be used instead of Vancomycin or Linezolid will it
win on price or ?
what sort of revenue are we looking at ?
how much of the market will Iclaprim capture ?

WJ.

[small crow] 04/1/2018 14:24

Yes, and then you ask yourself "Why SO much effort?" Woof woosh, as they say.

[toolsmoker] 04/1/2018 14:13

Still amazed we are here to be honest .one of the most manipulated stocks I've seen

[longshanks] 04/1/2018 13:26

Woof woof.Next leg up to 45p soon.

[pjj71] 04/1/2018 12:58

nothing seems to help this dog of a share.. despite all the good news!

[small crow] 04/1/2018 12:46

Bounce off 35?

[longshanks] 02/1/2018 22:34

Odd drop into the close, but the price is up in the US.

[chadders] 02/1/2018 13:33

A couple of nice buys this morning.

[waterloo01] 01/1/2018 19:26

Yes as in the presentation. Just reality bits. !

[pugugly] 01/1/2018 19:25

Odds on FDA approval ??